Gilead Sciences, Inc.'s Hepatitis C Drug Works Better: FDA Reviewers

Published: Oct 25, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Gilead Sciences Inc's drug sofosbuvir is safe and effective when used in combination with other therapies to treat hepatitis C, according to reviewers with the U.S. Food and Drug Administration. Their review was posted on the FDA website on Wednesday ahead of a meeting on Oct. 25 of an outside panel of medical experts who will recommend whether or not the agency should approve the drug.

Help employers find you! Check out all the jobs and post your resume.

Back to news